Current Status of Monoclonal Antibodies-Based Therapies in Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis of Clinical Trials

Background Multiple patients with prostate cancer become resistant to castration therapies, which is termed castration-resistant prostate cancer (CRPC). Purpose The purpose of this review is to assess the status of efficacy (≥50% decline in prostate-specific antigen (PSA), progression-free survival...

Descripción completa

Detalles Bibliográficos
Autores principales: Tarrar, Talha Azam, Anwar, Muhammad Yasir, Ali, Muhammad Ashar, Saeed, Memoona, Rehman, Sana, Bajwa, Shammas F, Ayub, Tooba, Javid, Haleema, Ali, Rimsha, Irshad, Alaa, Aiman, Wajeeha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Urology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989703/
https://www.ncbi.nlm.nih.gov/pubmed/35411277
http://dx.doi.org/10.7759/cureus.22942

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989703/
https://www.ncbi.nlm.nih.gov/pubmed/35411277
http://dx.doi.org/10.7759/cureus.22942

Ejemplares similares